Enerisant
Enerisant is a histamine H3 receptor antagonist. In H3 receptor binding assay using (R)-α-methyl[3H]histamine, Enerisant showed IC50 of 4.9 nM. Enerisant may be useful for the treatment of Alzheimer's disease, schizophrenia, etc.
| Supplier | Ace Therapeutics |
|---|---|
| Product # | SMD1500 |
| CAS # | 1152747-82-4 (free base) |
| Pricing | Customizable size, Inquiry |
| Synonym | Enerisant |
| Product Category | Lab-use Small Molecule Drugs |
| Chemical Formula | C22H30N4O3 |
| Exact Mass | 398.23179 |
| Molecular Weight | 398.51 |
| Elemental Analysis | C, 66.31; H, 7.59; N, 14.06; O, 12.04 |
| IUPAC/Chemical Name | (R)-(1-(4-(3-(2-methylpyrrolidin-1-yl)propoxy)phenyl)-1H-pyrazol-4-yl)(morpholino)methanone |
| InChi Key | IABXVJILZYNSTM-GOSISDBHSA-N |
| InChi Code | InChI=1S/C22H30N4O3/c1-18-4-2-9-24(18)10-3-13-29-21-7-5-20(6-8-21)26-17-19(16-23-26)22(27)25-11-14-28-15-12-25/h5-8,16-18H,2-4,9-15H2,1H3/t18-/m1/s1 |
| SMILES Code | O=C(C1=CN(C2=CC=C(OCCCN3[C@H](C)CCC3)C=C2)N=C1)N4CCOCC4 |
| Appearance | Solid powder |
| Purity | >98% (or refer to the Certificate of Analysis) |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| Storage Condition | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO, not in water |
| Shelf Life | >2 years if stored properly |
| Drug Formulation | This drug may be formulated in DMSO |
| Stock Solution Storage | 0 - 4℃ for short term (days to weeks), or -20℃ for long term (months). |
| HS Tariff Code | 2934.99.9001 |